Ivermectin in COVID-19: What do we know?

Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1921-1922. doi: 10.1016/j.dsx.2020.09.027. Epub 2020 Sep 28.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Animals
  • Antiparasitic Agents / therapeutic use
  • COVID-19 / epidemiology
  • COVID-19 Drug Treatment*
  • Clinical Trials as Topic / methods
  • Humans
  • Ivermectin / therapeutic use*
  • SARS-CoV-2 / drug effects*

Substances

  • Antiparasitic Agents
  • Ivermectin